The pharmaceutical companies Pfizer and Valneva say their vaccine shows promising results, as they seek Food and Drug ...

The drugmaker is seeking regulatory review for the first new shot to combat the disease in decades.

Pfizer is working to get approval on a new vaccine that could protect people against Lyme disease.

The vaccine demonstrated a reduction in the rate of infections, but fell short of a key statistical requirement.

Lyme disease infects hundreds of thousands of people each year and now scientists may be on the verge of a breakthrough with ...

The first human Lyme disease vaccine was 73% effective against the tick-borne illness, says Pfizer. They still plan to seek ...

Researchers are hoping the threat of Lyme disease could become a thing of the past. Advertisement. About Our Ads; About Our ...

Earlier this week, pharmaceutical company Pfizer and its partner Valneva announced that an experimental Lyme disease vaccine ...

If approved by regulators, it could become the only Lyme disease vaccine available for people — although it would not be the ...

Pfizer's shot fell short of its trial goal, but with nearly half a million Americans infected each year, the company isn't ...

The companies said the vaccine was 73% effective in reducing the rate of Lyme disease 28 days after the fourth dose.

There hasn't been an approved Lyme disease vaccine for more than 20 years, after GSK pulled its shot because of a lack of ...